ArticleCureus2024

Refractory Dupilumab-Induced Inflammatory Arthritis Treated by Upadacitinib: A 'Janus Kinase (JAK)' of All Trades.

Shiamak Cooper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.